首页/数据集/Genomic predictors of response to doxorubicin versus docetaxel in breast cancer

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer

ChEBI2011-05-27 更新2026-07-21 收录

肿瘤基因组学

个体化预测

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-21997 数据链接链接失效反馈

官方服务：

资源简介：

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer

应用场景：

创建时间：

2011-05-27

肿瘤基因组学

靶向治疗预后

BackgroundEchinoderm microtubule-associated protein-like 4 (EML4) is the canonical anaplastic lymphoma kinase (ALK) fusion partner in non-small cell lung cancer (NSCLC), and ALK-positive patients show

NIAID Data Ecosystem50

Additional file 8: of Valection: design optimization for validation and verification studies

肿瘤基因组学

变异检测

Table S7. A table of all predicted SNVs for tumour IS3, annotated by chromosome (“chrom”) and position (“pos”), and a “truth” column for whether the call is a true positive (1) or not (0). (CSV 328 kb

DataCite Commons2020-08-28 更新40

Results of Chi-Squared tests of association between mutational status and demographic and clinicopathological characteristics.

肿瘤基因组学

临床关联分析

Results of Chi-Squared tests of association between mutational status and demographic and clinicopathological characteristics.

Figshare2021-05-12 更新20

Additional file 1 of Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme

胶质母细胞瘤预后

肿瘤基因组学

Additional file 1.

Figshare2022-06-13 更新50

Distribution of TP53 and FGFR3 somatic mutations in LG and HG tumors.